Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Blackstone Life Sciences
Entity

Blackstone Life Sciences

Tracked across 1 events · 7 articles · First seen Feb 23, 2026 · Last active Feb 23, 2026

Sentiment
70
Attention
4
Events
1
Relationships
3
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 70
Business
Blackstone Life Sciences, Johnson & Johnson Fund Bleximenib
Blackstone Life Sciences has entered into a co-funding agreement with Johnson & Johnson to advance the clinical development of bleximenib for acute myeloid leukemia. This agreement highlights Blackstone Life Sciences' commitment to accelerating innovation in the life sciences sector and expanding its network of global leaders.
Feb 23, 2026 · 7 articles
Relationships (3)
Ari Brettman Senior Managing Director ↔ Blackstone Life Sciences Ari Brettman is a Senior Managing Director at Blackstone Life Sciences.
Nicholas Galakatos Global Head ↔ Blackstone Life Sciences Nicholas Galakatos is the Global Head of Blackstone Life Sciences.
Johnson & Johnson ↔ Blackstone Life Sciences Unknown
NEWSDESK
Track Blackstone Life Sciences live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.